ImageneBio (IMA) Retained Earnings (2020 - 2025)
ImageneBio (IMA) posted Retained Earnings of $363.1 million for Q4 2025, little changed sequentially from $362.9 million in Q3 2025, and up 301.83% YoY from $90.4 million in Q4 2024.
ImageneBio (IMA) Retained Earnings (2020 - 2025) Analysis & Trends
ImageneBio has reported Retained Earnings for 6 years, with the latest figure at $363.1 million in Q4 2025.
- Quarterly Retained Earnings rose 301.83% year-over-year to $363.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $363.1 million (up 301.83% YoY) and the FY2025 annual result came in at $363.1 million, up 301.83% from the prior year.
- Retained Earnings steadied at $363.1 million in Q4 2025 per IMA's latest filing, from $362.9 million in the prior quarter.
- Over five years, Retained Earnings peaked at $458.8 million in Q2 2025 and troughed at -$179.9 million in Q4 2024.
- A 5-year average of $365.3 million and a median of $363.0 million in 2025 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2021 and 2024: Retained Earnings soared 417.31% in 2021, then slumped 139.79% in 2024.
- Over 5 years, Retained Earnings stood at $353.3 million in 2021, then gained by 2.44% to $361.9 million in 2022, then increased by 24.93% to $452.1 million in 2023, then plunged by 139.79% to -$179.9 million in 2024, then jumped by 301.83% to $363.1 million in 2025.
- According to Business Quant data, Retained Earnings over the past three periods registered $363.1 million, $362.9 million, and $458.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -6.33 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.57 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 4.38 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 20.91 Bn |
| 10 | ImageneBio | 48.60 Mn | -86.75 Mn | - | 363.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 363.09 Mn |
| Sep 30, 2025 | 362.87 Mn |
| Jun 30, 2025 | 458.80 Mn |
| Mar 31, 2025 | 458.34 Mn |
| Dec 31, 2024 | -179.90 Mn |
| Sep 30, 2024 | 456.44 Mn |
| Jun 30, 2024 | 455.42 Mn |
| Mar 31, 2024 | 454.14 Mn |
| Dec 31, 2023 | 452.14 Mn |
| Sep 30, 2023 | 418.49 Mn |
| Jun 30, 2023 | 402.67 Mn |
| Mar 31, 2023 | 363.92 Mn |
| Dec 31, 2022 | 361.92 Mn |
| Sep 30, 2022 | 360.06 Mn |
| Jun 30, 2022 | 358.22 Mn |
| Mar 31, 2022 | 355.69 Mn |
| Dec 31, 2021 | 353.30 Mn |
| Sep 30, 2021 | 351.48 Mn |
| Jun 30, 2021 | 349.96 Mn |
| Mar 31, 2021 | 348.66 Mn |